Agonistic and Antagonistic Effects of Antiestrogens in Different Target Organs
- 1 January 1992
- journal article
- review article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 31 (2) , 143-146
- https://doi.org/10.3109/02841869209088894
Abstract
Antiestrogens block by definition specifically the actions of estrogens. In the classical uterotropic assay in immature rodents, where estrogens cause fluid retention and cell proliferation, triphenylethyle-nes have also species-specific estrogen-like (agonistic) effects. 4-hydroxylated triphenylethylenes have in general less estrogenic properties than unhydroxylated ones, and ICI 164,384 has no estrogenic activity in this model. Uterus responds to estrogens by stimulation of cell proliferation. Some other tissues, like breast, liver, and bone respond by regulation of specific protein synthesis. Some of the proteins act as growth factors, and some have unknown functions. The regulation of gene expression is a complex phenomenon: estrogens may turn the responsive gene on or off. Similarly antiestrogens may participate in the gene regulation by mimicking or antagonising estrogen-like actions. This paper summarizes the estrogenic and antiestrogenic effects of classical and new antiestrogens in different tissues.Keywords
This publication has 17 references indexed in Scilit:
- The Mechanism of ICI 164,384 Antiestrogenieity Involves Rapid Loss of Estrogen Receptor in Uterine TissueEndocrinology, 1991
- Dose-Dependent Effects of Tamoxifen on Long Bones in Growing Rats: Influence of Ovarian Status*Endocrinology, 1991
- Preclinical studies with toremifene as an antitumor agentBreast Cancer Research and Treatment, 1990
- Effect of toremifene on estrogen primed vaginal mucosa in postmenopausal womenJournal of Steroid Biochemistry, 1990
- Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: Phase I studyJournal of Steroid Biochemistry, 1990
- Novel Pure Antiestrogens. Mode of Action and Therapeutic ProspectsAnnals of the New York Academy of Sciences, 1990
- Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levelsBreast Cancer Research and Treatment, 1988
- The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation functionCell, 1988
- Acceptor Sites on Chromatin for Receptor Bound by EstrogenVersusAntiestrogen in Antiestrogen-Sensitive and -Resistant MCF-7 Cells*Endocrinology, 1986
- Effects of MER-29, a cholesterol synthesis inhibitor, on mammalian tissue lipidesArchives of Biochemistry and Biophysics, 1959